Zentek Ltd., a company operating within the health care sector of the metals & mining industry, has recently achieved a significant regulatory milestone. The company, which specializes in the development of nano-material technologies and composites, announced that Health Canada’s Pesticides Regulatory Directorate has reclassified its ZenGUARD™ Enhanced Air Filters as not subject to the Pest Control Products Act. This reclassification permits the commercial sale of ZenGUARD™ Enhanced Air Filters within Canada, marking a pivotal moment for Zentek Ltd.
The ZenGUARD™ Enhanced Air Filters, which utilize a graphene-based coating, are designed to improve filtration performance without increasing pressure drop or energy consumption. This feature has been validated through testing in accordance with ASHRAE Standard 52.2. The reclassification by Health Canada effectively removes a significant regulatory barrier, allowing Zentek Ltd. to pursue commercial sales across various sectors, including commercial, institutional, healthcare, and industrial markets.
In light of this development, Zentek Ltd. is actively accepting orders and is exploring federal procurement opportunities. The company is also focusing on licensing and the sale of coated filter media to participants within the HVAC supply chain. This strategic move is expected to enhance the company’s market presence and drive further commercialization of its innovative products.
Zentek’s CEO has highlighted that the regulatory decision clears the primary obstacle to market entry, enabling the company to shift its focus towards commercial execution and the exploration of additional commercialization pathways. This development is anticipated to bolster Zentek’s broader portfolio, which includes Albany Graphite and Triera, as well as its ongoing efforts in the development of critical mineral assets.
Financially, Zentek Ltd. is listed on the TSX Venture Exchange, with a market capitalization of 87,110,280 CAD. As of May 6, 2026, the company’s close price was 0.81 CAD, with a 52-week high of 2.33 CAD on May 11, 2025, and a 52-week low of 0.56 CAD on April 27, 2026. The company’s price-to-earnings ratio stands at -8.56, reflecting its current financial position.
Zentek Ltd. continues to serve its customer base exclusively in Canada, with further information available on its website at www.zentek.com . The company’s recent regulatory success is expected to play a crucial role in its future growth and expansion within the health care and metals & mining sectors.
